STOCK TITAN

ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ObsEva SA (NASDAQ: OBSV), a biopharmaceutical company focused on women’s reproductive health, will participate in the SVB Leerink 10th Annual Global Healthcare Conference on February 24, 2021, at 8:40 AM ET. The management will engage in a fireside chat and one-on-one investor meetings. Interested parties can access the presentation via a live webcast.

ObsEva is developing innovative therapies aimed at conditions such as endometriosis, uterine fibroids, and preterm labor, enhancing women's health outcomes.

Positive
  • None.
Negative
  • None.

 

Geneva, Switzerland and Boston, MA – February 17, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that Company Management will be participating in a fireside chat and one-on-one investor meetings at the SVB Leerink 10th Annual Global Healthcare Conference.

 

Details on the presentation can be found below.

 

Date: Wednesday, February 24, 2021

Time:8:40 AM ET

Webcast:Click Here

 

The presentation and archived webcast will also be accessible under “Events Calendar” in the investors section of ObsEva’s website.

 

About ObsEva

ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids and preterm labor. ObsEva is listed on the NASDAQ Global Select Market and is trading under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.

 

For further information, please contact:

CEO Office contact
Shauna Dillon
Shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact
Joyce Allaire
jallaire@lifesciadvisors.com
+1 (617)-435-6602

 

 

 

Attachment


FAQ

What date will ObsEva present at the SVB Leerink Conference?

ObsEva will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 24, 2021.

What time is the ObsEva presentation scheduled?

The ObsEva presentation is scheduled for 8:40 AM ET.

Where can I watch the ObsEva conference presentation?

You can watch the ObsEva conference presentation via a live webcast, with details available in the press release.

What is the focus of ObsEva's therapies?

ObsEva focuses on developing therapies to improve women's reproductive health, specifically for conditions like endometriosis, uterine fibroids, and preterm labor.

What is the stock symbol for ObsEva?

The stock symbol for ObsEva is OBSV on NASDAQ.

OBSV

NASDAQ:OBSV

OBSV Rankings

OBSV Latest News

OBSV Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link
Switzerland
Plan Les Ouates